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As veterinary pathologists, we have a broad knowledge of disease processes in an array of species 
with variable physiology and response to disease. The breadth of areas where veterinary patholo-
gists are active has led us to sub-specialize in particular species, organ systems, infectious agents, 
or sub-disciplines, such as forensic science. We are a group with tremendously diverse interests 
and expertise that includes basic and clinically applied research, drug discovery and preclinical 
toxicologic testing, diagnostic testing and quality assurance, public health and governmental policy, 
public outreach, and education. Our diversity of interests is both a strength and a challenge. Should 
we strive to maintain a unified discipline or divest into defined subspecialties? How should we define 
ourselves as pathologists? What core skill sets and competences should we include for certification 
and how do we prepare our trainees for the future? Should we have one international certification? 
Finally, how do we make our trainees aware of the many opportunities available to them?
The American College of Veterinary Pathologists is addressing these challenges in part by revis-
ing the structure and content of the specialty board examination. A working group has also been 
established to develop a “strategic plan for the future.” This group convened at the 2015 annual 
meeting and, in its initial discussions, recognized that (1) veterinary pathologists must adapt and 
respond to the changing needs for our stakeholders and (2) a renewed importance should be placed 
on research in training programs.1 Although the working group is likely several years away from 
delivering final recommendations, it seems likely that emphasis will be placed on research training. 
There is currently no stipulation for a research component in residency programs. In my view, build-
ing the infrastructure to support investigative research as an integral part of our training programs 
would be a positive step forward. By expanding our knowledge and informing future diagnostic 
practice, research will help keep our discipline relevant, vital, and current. I believe that training in 
investigative research will stimulate critical thinking in our trainees and potentially increase their 
competitiveness and the qualified applicant pool for faculty and leadership positions. It will also help 
feed the intellectual curiosity that drives us.
Our field is defined by the juxtaposition of descriptive and mechanistic explorations of disease 
processes. Identifying abnormalities and characterizing known and emerging diseases is a critical 
facet of what we do. Salient examples include the pathologist’s role in recognizing the emergence of 
West Nile virus in the United States (1) and elucidating the fungal cause of white nose syndrome in 
bats (2). This descriptive research is an essential part of diagnostic pathology. Yet, we, as patholo-
gists, also study the step-by-step development of disease from the molecular and genetic level to 
the animal level. Our profession strives to develop tools to identify disease at its earliest stage, when 
interventions are more likely to be successful. This effort is crucial to global health, as diseased ani-
mals affect their environment causing downstream ecological effects on humans, plants, and other 
animals. To help us explore disease at all these levels and the complex interrelationships between 
1 http://www.acvp.org/PDF/2016_ACVP_June_Newsletter_WEB.pdf
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animal and human health, I believe we should continue to take 
advantage of new and emerging disciplines, incorporating them 
into our investigational pursuits, as outlined below. We can also 
forge new cross-disciplinary partnerships and become leaders 
and essential contributors in collaborative teams. We should 
strive to ask novel questions and challenge dogma in animal 
disease that will help inform human studies and increase our 
competitiveness with national funding agencies.
epiGeneticS and GeneticS
The genomes of several animal species have been sequenced and 
annotated, including dogs (3), cats,2 and horses.3 These resources 
have allowed us to employ genome-wide association mapping to 
identify genetic abnormalities in inbred animals with simple dis-
ease traits that have helped inform similar diseases and normal 
development in humans (4–6). These breakthroughs have in turn 
resulted in the development of diagnostic tests for the genetic 
traits, which has potential for reducing disease prevalence (6–8). 
Genetic screening has also revealed associations with specific 
loci for complex diseases (9). Further investigation of these loci 
may lead us to discover causative genes and develop relevant 
diagnostic tests. Despite the rapid advances in genomic map-
ping, many challenges remain. For example, we are just begin-
ning to explore epigenetic patterns in animals (10, 11) but lack 
important tools, such as promoter arrays. We also need more 
information on cancer genomes in animals. I expect that these 
tools will eventually be developed. Our discipline must be ready 
to incorporate these advances in genomics into our training and 
diagnostic programs.
nanOenGineerinG
The burgeoning field of biomedical engineering has rapidly mor-
phed from basic research into translational medicine, with the 
application of engineering principles to cancer diagnostics, drug 
delivery, imaging, and infectious disease detection, to name a few 
applications (12–15). This field, together with genomic analysis, 
has ushered in personalized medicine in humans. Application 
of nanoengineering tools has just begun in veterinary medicine 
(16–18), but the goal of personalized medicine for pet animals is 
likely to come sooner rather than later. As pathologists, we hold 
a unique position where we can be both leaders and an integral 
member of multidisciplinary teams in the charge toward person-
alized medicine.
diaGnOStic iMaGinG
The introduction of powerful advanced techniques, such as 
imaging flow cytometry (19–21) and histology-directed imag-
ing mass spectrophotometry (22), is yielding new insights into 
disease pathogenesis. As dedicated instruments become more 
commonplace and cost-effective, it will only be a matter of time 
2 http://www.ncbi.nlm.nih.gov/genome?term=felis%20catus
3 http://www.uky.edu/Ag/Horsemap/
before these technologies enter the diagnostic realm. I, for one, 
am excited by the opportunity that these modalities represent. 
Pinpoint accuracy for infectious disease diagnosis, novel insights 
into biochemical pathways that lead to pathology – the possibili-
ties are endless.
cOnSenSUS StateMentS and 
StandardiZatiOn OF teStinG
Unlike human medicine, our diagnostic activities are not feder-
ally regulated. Veterinary diagnostic laboratories do not have to 
follow Clinical Laboratory Improvement Amendments regula-
tions.4 Nevertheless, many laboratories voluntarily participate 
in external proficiency testing, with recommendations for this 
testing being established by the American Society of Veterinary 
Clinical Pathology (23). Guidelines and consensus statements 
have been generated for several diagnostic activities, including 
reference interval establishment (24), prognostic markers in 
cancer (25), flow cytometric reporting in canine hematopoietic 
neoplasia (26), immunocytochemical staining (27), and viscoe-
lastic-based hemostasis testing (28), to name a few examples. 
Similarly, cytologic (29) and histologic (30, 31) grading schemes 
have been proposed for various tumors. Importantly, these 
guidelines are the culmination of efforts of multiple investiga-
tors and truly represent a global approach (“One Pathology”). 
Their frequency of citation and routine application during 
diagnostic testing attests to the usefulness of these guidelines. 
I believe that there is a clear need for new guidelines for our vast 
array of assays, such as histopathologic tumor grading, clonality 
assays and reporting, and flow cytometric methods. Ideally, these 
guidelines should be grounded in evidence-based medicine and 
have a built-in plan for re-evaluation. Up-to-date guidelines are 
crucial for standardization and allow cross-laboratory compari-
son of results, increasing the usefulness of results and our con-
fidence in the provided data. There is also a need for increased 
availability of affordable veterinary-specific proficiency testing. 
This is particularly pertinent for assays that use species-specific 
reagents, such as flow cytometry and clonality testing. In the 
absence of enforced regulation, it falls to us, the pathologists, and 
our Colleges and Societies, to generate more of these consensus 
statements or recommendations for standardization of testing 
and reporting.
hUMan–WildliFe BOUndarieS
Human activity continues to encroach upon uninhabited areas 
perturbing ecosystems and wildlife populations. A consequence 
of bringing human populations into close contact with previ-
ously isolated wild species is the interspecies transmission of 
infectious disease. Recently, we have seen outbreaks of Ebola and 
Zika viruses in humans, viruses that have previously been largely 
restricted to wildlife (32, 33). Conversely, viruses that are typi-
cally considered pathogens of domestic animals, such as canine 
distemper, have spread into naive wildlife, with devastating 
4 https://wwwn.cdc.gov/clia/
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effects (34). Technologic advances, such as hydrofracking, have 
allowed for the increased utilization of previously inaccessible 
natural resources. Yet, these come at a health cost to animals 
and humans (35). Wildlife species are sentinels of environmental 
changes, the proverbial “canary in the coal mine.” The emer-
gence and spread of fungal diseases, such as Pseudogymnoascus 
destructans (2) and chytridiomycosis (Batrachochytrium dendro-
batidis) (36), emphasizes our need to be continually and actively 
vigilant at screening wildlife for environmental changes that may 
affect human and animal health. Veterinary pathologists will 
continue to play a vital and prominent role in identification and 
investigation of these diseases.
The scope of this section of Frontiers in Veterinary Science 
is pathology – the study of disease – at a genetic (or epigenetic), 
molecular, cellular, tissue, organism, and herd level in animals. The 
scope encompasses the study of factors that contribute to disease, 
such as the aforementioned environmental changes. Our focus 
is animal health. Through improving animal health, we improve 
the health and well-being of humans, whose lives are intricately 
tied to and reliant on the animals that serve as food, companions, 
and workers. We accept various manuscript types5 and strongly 
encourage submission of prospective descriptive or hypothesis-
driven studies in topics related to pathology. To complement our 
current research topics, future planned research topics are hemat-
opoietic neoplasia, hemostasis, and wildlife as sentinels of disease.
So why publish in Frontiers in Veterinary Science?
• Open-access: this makes our research available to everyone.
• Rapid publication: with high expectations for productivity 
for early career pathologists, there is an urgent need for rapid 
publication. Fast turnaround times are only available through 
non-traditional publication avenues, such as open-access 
online journals. The average time from submission to online 
publication is around 2–3 months for Frontiers.
• Minimal stylistic editing: write your manuscript in active voice 
and your own style. Tell us your story.
• Copyright: authors retain copyright through a Creative 
Commons License. If you are a member of Linked-In, Research 
5 http://journal.frontiersin.org/journal/veterinary-science#article-types
Gate, Loop, or other professional networks, this allows you to 
post your articles or use your data without obtaining permis-
sion from a publisher.
• A collaborative interactive open review process: this can elim-
inate the frustrations, misconceptions, and seemingly endless 
revisions that inevitably accompany one-dimensional reviews. 
With Frontiers, authors discuss their rationale, clarify points, 
and address reviewers’ concerns through an online interactive 
forum with reviewers and the associate editor. Reviewers work 
with authors to help improve manuscript quality. Should your 
manuscript be accepted, the names of reviewers and associate 
editor are published. This encourages constructive, informa-
tive critical review.
• Assessment of impact: Frontiers has a tiered impact system, 
which takes advantage of the best of social networking and 
media. Impact is not only based on citations but also number 
of downloads, page views, etc. A question that remains to be 
answered is: Does this method works better than that already 
in use?
Our goals with Veterinary Experimental and Diagnostic 
Pathology are to publish high-quality research that showcases 
the breadth and strength of veterinary pathology and to advance 
our discipline. In doing so, we maintain our relevance and inspire 
our successors. Can we accomplish our goal? Only if you, the 
investigators, readers, and reviewers support this vision, ask the 
questions, and conduct the studies, then publish your results after 
collaborative, respectful, and thoughtful review. Why don’t you 
join us? I invite you to submit.
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